Analysts tweak 12-month target prices on Fisher & Paykel Healthcare

Analysts tweak 12-month target prices on Fisher & Paykel Healthcare
(Image: Fisher & Paykel Healthcare)
Rebecca Howard
Analysts rejigged their 12-month target prices on Fisher & Paykel Healthcare after it lifted its full-year guidance but retained fairly downbeat ratings. Last Friday, the healthcare products manufacturer lifted its full-year revenue guidance to $1.73 billion, from $1.7b, and net profit to $260 million-$265m, from $250m-$260m.Forsyth Barr analysts lifted their target price to $23.45 from $22.95. The shares last traded at $26.62.They noted that F&P Healthcare referenced stronger hospital consumables revenue and “homecare r...

More Markets

FPH, Fletcher drive NZ stocks lower
Markets Market Close

FPH, Fletcher drive NZ stocks lower

Dips for Fisher and Paykel Healthcare and Fletcher Building drive market down.

Jamie Gray 16 May 2025
Two executives depart Bremworth
Primary Sector

Two executives depart Bremworth

The two resignations follow chief executive Greg Smith's departure. 

Riley Kennedy 16 May 2025
Forsyth Barr sees future upside in Briscoe initiatives
Retail

Forsyth Barr sees future upside in Briscoe initiatives

Management gave details on the company's roadmap for growth at the AGM on Thursday.

Gregor Thompson 16 May 2025